The document provides an overview of a course on cardiovascular diseases (CVD). The 16-hour course will cover the etiology, pathophysiology, manifestations, risk factors, and management of various CVDs. It will also address diagnostic tests, medications, treatments, and rehabilitation services for CVD patients. The main objective is for students to acquire knowledge and skills to promote health, prevent illness, diagnose, manage and coordinate rehabilitation of CVD patients. Specific topics to be covered include anatomy and physiology of the heart and vessels, assessment of the cardiovascular system, and common CVDs and their management.
2. Course Outline For CVD
Introduction
• The cardiovascular diseases (CVD) conditions course
will be covered within 16 hours. By the end of the
course you will be able to compare and contrast the
etiology, pathophysiology and manifestations of
various cardiovascular conditions/diseases, explain
risk factors and preventive measures, describe
interdisciplinary and nursing care of CVS problems,
relate the outcomes of diagnostic tests and
procedures to pathophysiologies, discuss the effects
and nursing implications for medications and
treatments used, and describe rehabilitation
services.
3. Main Objective
• The student will be able to acquire knowledge,
attitude, and skills to be able to promote health,
prevent illness, diagnose, manage and coordinate
rehabilitation of patients suffering from
cardiovascular conditions/diseases.
Specific Objectives
• Review anatomy and physiology of the heart and
blood vessels
• Describe the assessment of cardiovascular system
• Describe common cardiovascular diseases and
conditions and their specific management
4. CONTENT
• Review of anatomy and physiology of the heart and vessels
• Assessment of cardiovascular system
• Congestive cardiac failure
• Rheumatic heart disease
• Valvular heart disease
• Coronary heart disease
• Arteriosclerosis
• Gangrene
• Varicose vein
• Thrombophlebitis (superficial and deep venous thrombosis)
• Arterial Thrombosis
• Arterial Embolism
• Hypertension (essential/malignant)
5. Mode of teaching
• Lectures/discussions
• Assignments
• Group discussions
Teaching/learning materials
• Handouts
• LCD/PowerPoint slides
• Flipcharts
• Blackboard
• White board
• Overhead projector/transparencies
• Textbooks
6. Mode of assessment for the course
• Completion of assignment 10%
• Quizzes 10%
• Mid-Semister test 20%
• End-block examination 60%
7. REFERENCE MATERIALS
• Aghababian, R. et al (2006). Essentials of Emergency
Medicine. Jones and Bartlett Publishers, London
• Bilotta, K. et al (Eds) (2009). Nurse’s Quick Check Diseases.
Wolters Kluwer, New York.
• LeMone et al (2011). Medical-Surgical Nursing. Pearson
Publishers, London.
• Lewis et al (2011). Medical Surgical Nursing. Elsevier
Publishers, London.
• Smeltzer S et al (2014). Brunner and Suddarth’s Medical –
Surgical Nursing. Lipppincot Company, Philadelphia.
Facilitator: David Onsongo
9. Aim:
By the end of the study the students will be
able to understand the concepts of how the
heart functions
10. Anatomy and physiology of CVS
Cardiovascular system(CVS) consists of:
• Heart - muscular blood pump organ
• Arteries– Carry blood away from the heart
• Veins- Return venous blood to the heart
• Capillaries- smallest blood vessels involved in
actual
exchange of materials between tissue cells and
blood
NB. Review more about the major blood vessels
11. Heart:
• Hollow muscular organ
• Occupies mediastinum space
• Weighs about 300 g (about size of owner’s fist)
• Pumps blood to supply oxygen and nutrients to
all tissues
Heart layers:
• Inner layer (endocardium)
• Middle layer (myocardium)
• Outer layer (pericardium)
visceral pericardium
peripheral pericardium
pericardial space: contains 30 ml lubrication
fluid
12. Heart chambers:
• Right atrium –Receives venous (deoxygenated)
blood
• Left atrium – receives oxygenated blood from the
lungs
• Right ventricle – Sends deoxygenated blood to the
lungs
• Left ventricle – Distributes oxygenated blood to
body tissues
Cardiac wall thickness:
• Atrial walls are thinner than ventricle walls
• Left ventricle wall is two and half times thicker than
right ventricle
• Left ventricle has higher pressure than right
ventricle and atria
13. Position:
• Heart lies in rotated position in thoracic space
• Right ventricle lies anteriorly just below the sternum
• Left ventricle is located posteriorly
• Apical beat obtained from left ventricle at left
midclavicular line in the 5th intercostal space
Valves:
• Tricuspid valve- between R. atrium and R. ventricle
• Bicuspid valve- between L. atrium and L. ventricle
• Pulmonic valve- between R. ventricle and pulmonary
artery
• Aortic valve- between L. ventricle and Aorta
14. Heart Sounds:
• Mitral and tricuspid valve closure produces first
heart sound (S1)
• Aortic and pulmonic valves closure produces
second sound (S2)
Abnormal Heart Sounds:
• Gallop sounds – occurs during ventricular
filling when there is impediment
gallop sounds comes in triplets with acoustic
effect of a galloping horse (sound produced by a
rapid moving horse)
15. Two kinds of gallop are S3 and S4
S3 results from rapid ventricular filling phase, may
be normal in children and young adults. S3 is
associated with:
myocardial diseases
inability of ventricles to eject all blood during
contraction
S3 can be heard best when patient is lying on the
left and sounds like, ‘Lub-dub-DUB’
S4, which sounds “LUB lub-dub” occurs during
atrial contraction in:
enlarged ventricles which resist filling associated
with hypertrophy common in hypertension, CHD, and
aortic stenosis
16. Cont. of abnormal sounds
• Snaps and Clicks:
Results from mitral stenosis (narrowing)
Characterised by high pitched sound heard
very early in diastole
They are caused by high pressure in left
atrium when it abruptly displaces a rigid mitral
valve
It commonly causes murmurs specific to
mitral stenosis
17. • Murmurs: caused by turbulent flow of blood
due to
Serious narrowed valve
Malfunction valve that allows backflow of
blood
congenital defect of ventricular wall
Defect between aorta and pulmonary
artery
Increased blood flow thru normal structure
in conditions with
pyrexia, pregnancy, increased thyroid
activity
18. Cont. of abnormal sounds
•Friction rub:
Pericarditis causes a harsh, grating sound heard
in both systole and diastole termed as friction rub
Pericardial rub is best heard when using
diaphragm of stethoscope while patient is in upright
position
19. Cardiac conducting system:
• Organized atrial and ventricular contraction to
ensure coordinated and controlled filling and
empting
• Cardiac cells contract and relax due to
stimulation
• Two major cardiac cells are:
Unspecialized myocardial cells for
contraction
20. Automatic cells specialized for impulse
formation
• Main bulk of atrial and ventricular muscles
are unspecialized
myocardial cells
• Adjacent myocardial cells are held together
by complex
system of projections – intercalated discs –
with relatively low
electrical resistance
21. Cardiac conducting system cont.
• Easy movement of electrically charged ions from
one myocardial to others to propagate action
potentials
• Main ions are Na+, K+ and Ca++
• Myocardial cells are polarised in normal resting
state
• Stimulation of myocardial cells changes cell
membrane permeability allowing ions movement,
thereby changing electrical polarity (depolarisation)
22. • Depolarised myocardial cells have positive
intracellular ions and negative extracellular ions
• After depolarisation, repolarisation – returning to
resting state – involves active pumping of ions
against concentration gradient
• Automatic cells regulate myocardial cells
contraction by providing initial electrical
stimulation
23. Cont of cardiac conducting syst.
• Automatic cells consists of 3 properties:
Automaticity – ability to generate action
potential, spontaneous and regularly
Excitability – ability to respond to electrical
stimulation by stimulating action potential
Conductivity – ability to propagate action
potential
Refractoriness – inability to respond to new
stimuli while in contraction (depolarised)
state
24. • Electrical charge on surface of automatic cell
leaks away until certain threshold is reached
• Then , spontaneous complete depolarisation
occurs over the whole cell surface and spreads
to adjacent cells (to both automatic and
unspecialized cells)
• Automatic cell with most rapid leak of charge
becomes the pacemaker (normally located
within SA node)
• Automatic cell in cardiac conducting system are:
SA node (Sinus node), AV node, Bundle of His,
left and right bundle branches
25. Sequence of excitation:
• Depolarisation begins at SA node and spreads
through both atria
• Activating impulse travel 1 m/s and reaches most
distant atria in about 0.08 seconds (P wave in ECG)
• Atria and ventricles remain electrically separate
except via AV junction, which allows potential action
be conducted from atrial to ventricular conducting
system
26. • When impulse reaches AV node, there is a delay
of about 0.04s to allow blood flow from atria to
ventricles
• After emerging from AV node, impulse reaches
the rapidly conducting tissue of bundle of His and
left and right bundle branches
• Impulse spreads rapidly throughout ventricles via
purkije fibres, thereby depolarising the ventricles
causing efficient ventricular contraction to pump
blood out of the heart
27. Electrocardiography (ECG):
• Graphic recording from body surface of potential
differences resulting from current generated in the
heart
• ECG is recorded on special graphic paper or on
oscilloscope (monitor) and it is recorded against
time
• ECG detects and interprets Cardiac arrhythmias,
diagnosis of CHD, ventrical enlargement or
hypertrophy
28. • Electrical sequential events produced at each
heart beat is labeled PQRS and T
• P wave results from atrial activation
(depolarisation), P width represent the time
necessary for atrial activation process (0.08s)
• Approximately 0.1 s after P wave begins, the
atria contracts
• PR interval is measured from starting of P wave
to beginning of QRS complex that reflects time
taken for action potential to spread from SA node,
AV node, bundle of His into ventricular
mass
29. Cont of ECG
• QSR waves reflect ventricular activation. Q is
downward deflection after P wave. R wave is the
first upward deflection. Then, downward deflection
after R is S wave.
• P-R interval, represents time impulse takes to
spread from atria to ventricles (takes 0.12-0.20
s, average 0.16 s)
• QRS complex shows length of time action
potential takes through the ventricles
(ventricular depolarization time, 0.08 s)
30. • ST segment is a flat line between S wave and T
wave, representing the early phase of ventricular
muscle repolarisation (recovery)
• Q-T interval represents electrical systole (varies
in age, sex and heart rate)- takes up to 0.38-o.43s,
normally inversely related to HR
• T wave represents the actual recovery of the
ventricle muscle (repolarisation)- takes about 0.16
seconds
31. Excitation – contraction coupling:
• Excitation-contraction coupling describes the link
between electrical events and myocardial muscle
contraction
• When action potential passes over cardiac cell
membrane it passes into the interior of each muscle
cell down a series of fine branching tubules until it
reaches the cells contractile elements to stimulate
release of Ca++ ions
• Ca++ ions act as catalysts for chemical reaction to
activate the sliding of thin muscle filaments
(myofilaments) over each other to produce
contraction
• Myocardial contraction strength partly depends on
intracellular concentration of free Ca++
32. Cardiac cycle:
• Cardiac cycle – cyclical contraction (systole) and
relaxation (diastole) of atria and ventricles
• Initiation of each cycle is by spontaneous
generation of action potential in SA node
• Each chamber fills with blood during diastole
• Diastole lasts 0.4 s during which blood enters
atria and flows passively into ventricles
33. • Mitral and tricuspid valves open and aortic and
pulmonic valves close during ventricular diastole
• Blood is expelled from ventricles during systole
• Atria contract fractionally before the ventricles
and complete ventricular filling
• Then ventricles begin to contract (systole),
increasing pressure closes mitral and tricuspid
valves and opens semilunar valves
34. Cont. of cardiac cycle
• Ventricular contraction pushes blood into pulmonary
artery and aorta
• During diastole pressure within ventricles falls bellow
the pressure in major arteries, thus pulmonic and aortic
valves close. Then the cycle begins again.
• Normal HR for a resting adult is approximately 60- 80
bpm
• 65-75% of blood is ejected from the ventricles in each
systole
• SV is about 70-80 ml at rest
• CO is the product of SV x HR
• More informatively, CO can be measured using
cardiac index, in which CO/min/m2 of BSA is about 3.2
L/m2
35. Primary factors determining CO:
• Preload – the amount of tension on the ventricular muscle
fibres before they contract, determined primarily by EDV
• Afterload – the resistance against which the heart must pump,
and its major components are:
Blood pressure in aorta
Resistance in the peripheral vessels
The size of aortic valve opening
Left ventricular size
• Contractility of the heart
• Heart rate
According to Frank-Starling law of the heart, cardiac out put
matches venous return i.e. the heart adapts the changing loads
of inflowing blood from systemic and pulmonary circulations
36. Continuation
Within certain limits, the more cardiac muscle contracts
forcibly, the more they get stretched at the beginning of
contraction
Once venous return increases beyond certain limit, the
myocardium begin to fail
Regulation of the heart in response to the amount of blood
to be pumped is termed as intrinsic regulation
ANS regulation of cardiac function:
• ANS alters rate of impulse generated by SA node, the speed
of impulse conduction and the strength of cardiac contraction
• Stimulation of sympathetic nervous system (fibres) increase
HR, conduction speed through AV node and force of contraction
37. Ct of regulation cardiac function
• Parasympathetic stimulation via vagus nerve decreases HR,
conduction rate through AV node, and atrial conduction force
• ANS control of the heart occurs by reflexes coordinated in
medulla oblongata
• Cardiac centre is the group of brain neurons controlling heart
activity and blood vessels
• Cardiac centre receives information from various sensory
receptors e.g.
Baroreceptors – located in atria, aortic arch and carotid sinus-
generate impulse in response to changes in blood pressure
Chemoreceptors – located in carotid artery respond to changes
in the chemical composition of the blood
38. Blood supply:
• Heart receives 5% of cardiac output to maintain cellular
activity
• Blood supply is through right and left coronary arteries
• Branches of left coronary artery: left anterior interventri-
cular (descending) artery (LAD) and circumflex artery (CX)
• Right coronary branches: posterior interventricular artery
(PIA) and marginal artery (MA)
• LAD innervates interventricular septum and anterior walls
of both ventricles. CX supplies lateral and posterior L. atrium
and L. ventricle.
• PIA innervates posterior ventricular walls. MA serves right
ventricle
• Normally, right coronary artery supplies blood to SA and
AV nodes
39. Arterial blood pressure (ABP):
• ABP is measurement of pressure exerted by blood as it flows
through the arterial walls – systolic and diastolic pressure
• Arterial blood pressure is the product of cardiac output times
peripheral resistance (CO x PR)
Determinants of blood pressure include:
the pumping action of the heart
the peripheral vascular resistance
blood volume
blood viscosity
• Normal determinants of pressure are:
Autonomic nervous system
Renin-angiotensin-aldosterone system
40. Factors affecting BP values:
• Age (increases with advancing age- arteriosclerosis)
• Exercise (increases)
• Emotional reaction (stress)
• Race (common in the blacks)
• Gender (common in males)
• Medications (e.g. vasoconstrictors, Glucocorticoids)
• Obesity
• Diurnal variation (lowest in AM and highest in PM)
• Position
• Disease process (Renal diseases)
• Sleep
• Digestion
41. Assessment of cardiovascular system
The CVS assessment comprises of
Health history
Physical exam
Diagnostic evaluation
42. Health history
Common symptoms
• Chest pain or discomfort (angina pectolaris, dysrrhythmia,
valvular heart disease)
• Shortness of breath or dyspnoea
• Peripheral oedema, weight gain, abdominal distension due
to enlarged spleen and liver or ascites
• Palpitations (tachycardia from variety of causes)
• Unusual fatigue, sometimes referred to as vital exhaustion
• Dizziness, syncope or changes in level of consciousness
(cardiogenic shock, cerebrovascular diseases,
dysrrhythmia, hypotension, postural hypotension,
vasovagal episode)
43. Health history
Past health, family and social history
• Any health changes within 5 years
• Any cardiovascular problems
• Any treatment of CVD
• medications
• Nutrition
44. Health history
• elimination
• activity and exercise
• sleep and rest
• self-perception and self-concept
• roles and relationships
• sexuality and reproduction
• coping and stress tolerance
48. Diagnostic evaluation
Diagnostic evaluation include:
• Laboratory tests
• Cardiac biomarker analysis
• Creatinase secreted by necrotic cardiac
muscles is part of diagnostic evaluation of CAD
and proteins myoglobin, troponin T, and
troponin I.
49. Diagnostic evaluation
• Blood chemistry, hematology and coagulation
studies
• Lipid profile
• Cholesterol levels normal is less than 200mg/dL
• Triglycerides normal between 100-200mg/dL
• LDLs normal levels less than 160mg/dL
• HDLs normal levels in men is between 35-70
mg/dL and women 35-85mg/dL
50. Diagnostic evaluation
• Brain (B-Type) natriuretic peptide –
neurohormone that regulates BP and fluid
volume
• C-Reactive protein: protein from the liver in
response to inflammation that plays a role in
atherosclerosis
• Homocysteine: an amino acid linked to
development of atherosclerosis because it
damages endothelial lining of arteries and
promotes thrombus formation
51. Diagnostic evaluation
• Chest X-Ray and Fluoroscopy
• Determines size, contour and position of heart
• Electrocardiography
• Continuous electrocardiographic Monitoring
• Hard wire cardiac monitoring
• Telemetry
• Ambulatory electrocardiography
• Transtelephonic monitoring
• Wireless mobile cardiac monitoring
52. Diagnostic evaluation
• Cardiac stress testing
• Exercise stress testing
• Pharmacologic stress monitoring
• Done in patients not able to perform exercise
stress testing
• Iv vasodilating drugs to mimic exercise effects
by maximally dilating coronary arteries are
given e.g. dipyridamole and adenosine
53. Diagnostic evaluation
• Echocardiography
• Transthoracic echocardiography
• Transesophageal echocardiography
• Radionuclide imaging
• Myocardial perfusion imaging
• Test of ventricular function and wall motion
• Computed tomography
• Positron emission tomography
• Magnetic resonance angiography
56. Hypertension
Introduction
Intermittent or sustained elevation of diastolic
equal/above 90 mmHg or systolic blood pressure
equal/above 140 mmHg on three separate
readings recorded weeks apart
Associated with: premature death, vascular
disease of the brain, heart and kidneys
Usually begins as benign disease, slowly
progressing to accelerated or Malignant state
Two major types: Essential (primary or
idiopathic) hypertension and secondary
hypertension, which result from renal disease or
another identifiable cause
Malignant hypertension, a medical emergency: a
57. Pathophysiology
• There several theories about pathophysiology
of hypertension
Changes in arteriolar bed cause increased
peripheral vascular resistance
Abnormally increased tone in the sympathetic
nervous system originating in the vasomotor
system centres causes increased peripheral
vascular resistance
58. pathophysiology
Increase in arteriolar thickening caused by
genetic factors leads to increased peripheral
resistance
Increased activity of renin-angiotensin-
aldosterone system, resulting in expansion of
extracellular fluid volume and increased
vascular resistance due to constriction of
arterioles by the effects of angiotensin II.
59. • Resistance to insulin action, which may be a
common factor linking hypertension, type two
diabetes, hypertriglyridemia, obesity, and
glucose intolerance
• Adaptation of the innate and adaptive
components of the immune response that
may contribute to renal inflammation and
dysfunction
60. • Increased renal reabsorption of sodium,
chloride, and water related to a genetic
variation in the pathways by which the
kidneys handle sodium
61. causes
• Causes for primary hypertension are unknown in most
cases, but with various predisposing factors
• 5% - 10% (secondary hypertension): due to underlying
conditions to include:
Kidney disease e.g renal failure
Coarctation (narrowing) of the aorta, causing hypertension
Endocrine disorders e.g. Cushings Syndrome,
pheochromocytoma (tumour in adrenal gland that
releases catecholamines; causes 2% of all hypertensions)
Neurologic disorders e.g. increased intracranial pressure
Certain medications, or illicit drugs
Pregnancy
62. Factors implicated as causes of HPN
Many factors have been implicated as causes of
hypertension:
• Increased sympathetic nervous system activity
related to dysfunction of the autonomic nervous
system
• Increased renal reabsorption of sodium, chloride,
and water related to a genetic variation in the
pathways by which the kidneys handle sodium
63. Factors implicated as causes of HPN
• Increased activity of the renin–angiotensin–
aldosterone system, resulting in expansion of
extracellular fluid volume and increased systemic
vascular resistance
• Decreased vasodilation of the arterioles related
to dysfunction of the vascular endothelium
• Resistance to insulin action, which may be a
common
factor linking hypertension, type 2 diabetes
mellitus,
hypertriglyceridemia, obesity, and glucose
intolerance
64. Risk Factors
• Family history of cardiovascular disease
• Genetic factors
• Race: Africans (the blacks)
• Stress
• Obesity
• High sodium intake
• Low potassium, calcium , and magnesium
intake
• High-saturated fat diet
• Impaired renal function (GFR < 60 ml/min
and/or microalbuminuria)
65. • Use of hormonal contraceptives
• Excess alcohol intake
• Use of tobacco
• Sedentary lifestyle
• Low socio-economic status
• Insulin resistance/ diabetes mellitus type 2
• Aging, above 55 years for men, above 65 years
for women
66. Incidence
• Primarily affects middle aged and older adults
• Primary hypertension: 90% - 95% of cases
• More than 50% of people aged 60 -74 years are
hypertensive
• 75% of those aged 75 and older are hypertensive
• Incidence of hypertension is her in the blacks
than the whites
67. Common characteristics/classifications
of blood pressure for adults
• Serial blood measurements in mmHg:
CATEGORY SYSTOLIC DIASTOLIC
Normal < 120 and < 80
Pre-hypertension 120 – 139 or 80 – 89
Hypertension:
stage I 140 – 159 or 90 – 99
stage II Equal or above or Equal or above
160 100
69. Diagnostic assessments
• History:
Many cases have no symptoms and the disorder
is revealed incidentally during an evaluation of
another disorder or during a routine blood
pressure screening program
Symptoms that reflect the effect of hypertension
on the organ system
Awakening with occipital headache, subsides
spontaneously after a few hours
70. History of:
• Fatigue, dizziness and confusion
• Palpitation, chest pain and dyspnoea
• Epistaxis
• Haematuria
• Blurred vision
71. Physical exam findings include:
• Bounding pulse
• S4
• Peripheral oedema in the late stages
• Hemorrhages, exudates, and papilledema of the eye in
late stage if hypertensive retinopathy present
• Elevated blood pressure on at least two consecutive
occasions after initial screening
• Bruits over the abdominal aorta and femoral arteries or
the carotids
• Palpating abdominal mass, suggesting an abdominal
aneurysm.
72. Lab Test Results
• Urinalysis: protein, RBCs, or WBCs, suggesting
renal disease, or glucose suggesting DM
• Serum potassium levels <5.5 mEq/L may indicate
adrenal dysfunction (primary hypertension)
• Blood urea nitrogen normal or elevated above 20
mg/dl suggesting renal disease
• Serum creatinine levels normal or elevated
above 1.5 mg/dl suggesting renal disease
73. Imaging Tests
• Excretory urography reveals renal atrophy,
indicating chronic renal disease, one kidney
more than 1.6 cm shorter than the other
suggests unilateral renal disease
• Chest x-ray may demonstrate cardiomegaly
• Renal arteriography may show renal artery
stenosis
74. Diagnostic procedures
• Electrocardiography may show left ventricular
or ischemia
• An oral captopril challenge may be done to
test for renovascular hypertension
• Ophthalmoscopy reveals arteriovenous
nicking and, in hypertensive encephalopathy,
oedema
76. General management
• For a patient with secondary hypertension,
correction of the underlying cause and control
of hypertensive effects
• Low saturated fat and low sodium diet
• Adequate calcium, potassium, and magnesium
in diet
77. Medications
• Diuretics to reduce blood volume, such as furosemide,
hydrochlorothiazide and indapamide
• Beta-adrenergic blockers such as atenolol and meteprolol
• Calcium channel blockers to block Ca+ access to cardiac
muscle to reduce contractility and conductivity, reduce
oxygen demand, relaxes arterioles (lowers periveral
vascular resistance): such as, verapamil, nifedipine,
felodipine, and nisoldipine
• Angiotensin converting enzyme inhibitors: such as
benazepril, captopril, and enalapril. Mainstay of
vasodilator therapy. More effective when used with
diuretics.
• Alpha-blockers, such as doxazosine, and prazosin
• Angiotensin-receptor blockers such as olmesartan,
candesartan, and irbesartan
78. Medications
• Vasodilators such as hydralazine, minoxidil
• Aldosterone antagonists such as eplerenone and
spironolactone
• Combination alpha-and beta-blockers such as
carvedilol and labetalol
• Alpha-receptor antagonist such as clonidine
• Direct Renin inhibiters e.g. alskiren (Tektuma),
indicated in mild to moderate hypertension to
block the conversion of angiotensinogen to
angiotensin I by inhibiting the activity of enzyme
renin. C/I in pregnancy.
79. Nursing management
Nursing diagnoses:
• Ineffective self-health management related to lack of
knowledge of the condition, complications,
management, unpleasant side-effects of drugs, failure to
achieve goal BP while on medication, return of BP to
normal while on medications, high cost of some
medications, inconvenient of taking drugs, lack of
trusting relationship with health care provider
• Anxiety related to complexity of management regimen,
possible complications and lifestyle changes associated
with hypertension
• Sexual dysfunction related to side-effects of
antihypertensive medications
80. Nursing diagnoses
• Disturbed body image related to diagnosis of
hypertension
• Imbalanced nutrition: more than body
requirement related to obesity, and alcohol
intake
• Excess fluid volume related to sodium
retention, disruption of renin-angiotensin-
aldosterone system
• Risk for decreased cardiac tissue perfusion
• Risk for ineffective cerebral tissue perfusion
• Risk for ineffective renal perfusion
82. Key nursing outcomes
• The patient will:
Maintain adequate cardiac output
Maintain hemodynamic stability
Develop no arrhythmias
Express feelings of increased energy
Comply with the therapy regimen
Develop no renal failure and stroke
83. Nursing interventions
• Administer prescribed drugs
• Encourage dietary changes as
appropriate
• Help patient identify risk factors and
modify his/her lifestyle
84. Monitoring:
o Vital signs, especially blood pressure
o Signs and symptoms of target end-organ
damage
o Complications
o Response to treatment
o Risk factor modification
o Adverse effects of antihypertensive agents
85. Patient teaching:
Be sure to cover:
The disorder, diagnosis and treatment
How to use a self-monitoring blood pressure
cuff and to record the reading in a journal for
review by the physician
The importance of compliance with
antihypertensive therapy and establishing a
daily routine for taking prescribed drugs
86. The need to report adverse effect of drugs
The need to avoid high-sodium antacids and over-
the-counter cold and sinus medications containing
harmful vasoconstrictors
Examining and modifying life-style including
diet
The need for routine exercise program, particularly
aerobic walking
Dietary restrictions: adopt DASH eating plan
(consuming diet rich in fruits, vegetables and low
fat)
Cessation of alcohol consumption
The importance of follow-up care
87. Dietary Approach to Stop
Hypertension (DASH)
• Grains: seven to eight servings per day
• Vegetables: four to five servings per day
• Fruits: four to five servings per day
• Nonfat/low-fat dairy products: two to three servings
per day
• Meats, poultry, and fish: two or less 3 oz servings
per day
• Nuts, seeds and dry beans: four to five servings per a
week
• Fats and oils: two to three servings per day
• Sweets: five servings per a week (should be low in
fat)
89. Hypertensive Crisis
• Significant, rapid elevations in systolic and/or diastolic
pressure. Two types: Hypertensive emergency and
hypertensive urgency.
• In hypertensive emergency or malignant hypertension, the
systolic pressure is above 180 mmHg or the diastolic
pressure is above 120 mmHg, associated with impending
or progressive organ dysfunction
• Immediate treatment, just within one hour, is vital to
prevent cardiac, brain, renal and vascular damage, and
reduce morbidity and mortality.
• Intensive cerebral artery spasm occurs to protect brain
from high pressure, but in turn, it complicates to cerebral
oedema
90. Hypertensive Emergency
• Associated with following organ dysfunction:
o hypertensive encephalopathy
o Hypertensive left ventricular infarction
o Hypertension with myocardial infarction
o Hypertension with unstable angina
o Hypertension with dissection of the aorta
o Hypertension with subarachnoid haemmorrhage or CVA
o Severe pre-eclampsia or eclampsia
o Crisis associated with phaechromocytoma
o Hypertension perioperatively
o Use of creational drugs e.g. Amphetamines, LSD,
Cocaine
91. Signs and symptoms of hypertensive
crises
• Rapid onset elevation of BP
• Blurred vision, papilledema
• Systolic pressure greater than 180 mmHg
• Diastolic pressure greater than 120 mmHg
• Severe headache
• Confusion/anxiety
• Nasal bleeding
• Motor and sensory deficits
92. Hypertensive Urgencies
• Isolated large blood pressure elevations without evidence
of acute Organ Dysfunction
• Elevated blood pressures with severe headaches, nose-
bleedings, or anxiety are classified as urgencies
• It is associated with treatment discontinuation or
reduction as well as anxiety
• It should not be treated as emergency but treated by
reinstitution or intensification of drug therapy and
treatment of anxiety
• Oral agents e.g. Labetalol (Beta blocker) and captopril
(CCB)or clonidine (Catapres) are given to reduce blood
pressure to normal in 24 to 48 hours.
• Monitor blood pressure in every 30 minutes till stable
93. Management of hypertensive
emergency
• Acute life-threatening blood pressure elevations requiring
prompt treatment in an intensive care setting because of
serious target organ damage that may occur
• This Pressure must be reduced by 20 to 25% in one hour
of treatment, and a further reduction to a goal pressure
of about 160/100 mmHg over a period of 6 hours
• Vasodilators e.g. sodium nitropruside, nitroglycerin,
diazoxide, hydralazine
• Calcium-channel blockers e.g. nicardipine
• ACE inhibitor e.g. enalaprilat
• Adrenergic blockers: labetalol, esmolol, phentolamine
• Monitor vital signs esp. BP in every 5 min, then 15 to 30
min interval when stable
94. HEART FAILURE
Introduction:
• Definition: It is a clinical syndrome resulting from
structural or functional cardiac disorders that
impair the ability of ventricles to fill or eject
blood (to meet the metabolic needs of the body)
[Hinkle & Cheever, 2014]
• Fluid buildup in the heart from myocardium that
can’t provide sufficient cardiac output
• Usually occurs in a damaged left ventricle but
may occur in right ventricle, either primarily or
secondary to left-sided heart failure
95. • Heart failure (HF) was referred to congestive
heart/Cardiac failure (CHF or CCF) due to many
patients present with pulmonary or peripheral
congestion with oedema
• Currently, HF is recognized as clinical syndrome
characterized by signs and symptoms of fluid overload
or inadequate tissue perfusion
• Fluid overload and decreased tissue perfusion occurs
when heart cannot generate sufficient cardiac (CO) to
meet body’s demand for oxygen and nutrients
• In heart failure, impaired contraction of the heart
(systolic dysfunction) or filling of the heart (diastolic
dysfunction) may cause pulmonary or systemic
congestion
96. Pathophysiology
Given according to the cause:
Left-sided verses right-sided failure
Systolic or diastolic failure
Low-output or high output failure
Acute or chronic failure
Forward or backward failure
97. Pathophysiology
• Left-sided Heart Failure:
Pumping ability of the left ventricle fails and cardiac output falls
Blood backs up in the left atrium and lungs, causing pulmonary
congestion and decreased cardiac output.
Causes include: hypertension, myocardial infarction of left
ventricle, or valvular heart disease
• Right-sided Heart Failure: (Cor pulmonale)
Ineffective contractile function of the right ventricle leads to
blood backing up into the right atrium, in the vena cava and the
peripheral circulation (venous system), which results in
peripheral edema and engorgement of the kidneys and other
organs.
Causes include: severe pulmonary disease and myocardial
infarction
98. Systolic or diastolic failure
Systolic heart failure:
Due to ventricle failure to contract adequately to
eject enough blood through aorta into arterial
system. Causes decreased ventricular blood ejection
Caused by loss of myocardial cells in ischemia,
myocardial infarction (contractile dysfunction),
cardiomyopathy or inflammations, increased
afterload (hypertension), mechanical abnormalities
(e.g. valvular disease)
manifested in effects of low CO e.g. weakness,
fatigue, exercise intolerance
Over time, it causes left ventricle dilatation and
hypertrophy
99. Diastolic heart failure:
Occurs when heart is unable to completely relax
(stiffness and non-compliant heart muscle) in diastole,
thus disrupts normal filling
Passive diastole filling decreases thereby decreasing
stroke volume and cardiac output, but increases atrial
contraction to preload
Diastolic function occurs from chronic hypertension (
most common), decreased ventricular compliance due
to hypertrophy, and impaired heart muscle contraction
Manifested by dyspnoea, tachypnoea, respiratory
crackles in if left ventricle affected and pulmonary
hypertension. Neck vein distension, liver enlargement,
anorexia, nausea, if right ventricle is affected
100. Low-output VS high-out failure:
Low-output failure
• Develops when there is a decrease in the biventricular
output resulting from: coronary heart disease,
hypertension, cardiomyopathy, and other primary cardiac
disorders.
High-output failure (increased/normal cardiac output)
• Hypermetabolic states increases CO to maintain blood
flow and O2 to tissues
• This activates compensatory mechanisms to increase CO
thus further increasing O2 demand
• Though high CO, the heart is unable to meet increased
demands of the tissues and thus fails
• Causes include: septicemia, anaemia, hyperthyroidism or
AV shunting
101. Acute VS chronic failure:
Acute failure: it’s life-threatening and occurs
abruptly resulting from myocardial injury e.g.
massive myocardial infarction manifested by sudden
decrease in cardiac function and signs of decreased
CO. Manifests as pulmonary oedema and
congestion
Chronic failure: progressive (gradual) decline or
deterioration of heart muscle, which allows
compensatory mechanisms to come into play. It
causes decreased cardiac output.
Causes include: cardiomyopathies, valvular disease,
or coronary heart disease (CHD)
102. Pathophysiology of Compensatory
mechanism leading to heart failure
• There are three primary compensatory
mechanisms are:
1. The Frank-Starling mechanism: that is, the
greater the stretch of the cardiac muscle, the
greater the force of contraction. This
increases contractile force thereby increasing
CO. Complications include: increased
myocardial demand; limited by
overstretching.
103. pathophysiology
2. Neuroendocrine response including
activation of SNS and RAAS
• Decreased CO induces SNS and catecholamine
release, thereby increasing HR, BP,
contractility, vascular resistance and venous
return.
• Complications include: tachycardia, decreased
filling time, low CO, increased vascular
resistance, increased myocardial work and O2
demand
104. pathophysiology
• Decreased CO and renal perfusion induce renin-
angiotensin system. This causes vasoconstriction and
increased BP. Complications include: increased
myocardial work, renal vasoconstriction, and
decreased renal perfusion
• ACE converts angiotensin I to angiotensin II, which
stimulates aldosterone release from renal cortex
resulting in salt and water retention by kidneys, and
increased vascular volume overload and
vasoconstriction, increasing BP and afterload.
Complications include: increased preload and
afterload; pulmonary congestion; increased stress on
ventricular wall (increased cardiac work-load).
105. pathophysiology
• ADH is released from neurohypophysis, which
inhibits water excretion; while atrial natriuretic
factor that is released from the heart increases
Na excretion and diuresis. Complications
include; fluid retention and increased preload
and afterload
• Blood flow is redistributed to vital organs (heart
and brain) thereby decreasing perfusion of other
organ systems, skin and muscles. Complications
include: renal failure, anaerobic metabolism, and
lactic acidosis.
106. pathophysiology
3. Ventricular hypertrophy:
• Increased cardiac workload causes myocardial
muscle to hypertrophy and ventricles to dilate.
• This in turn leads to increased contractile force to
maintain CO.
• This effect complicates into: increased
myocardial O2 demand and cellular enlargement
• The enlarged myocardial cells become
dysfunctional and die early (apoptosis), thus
leading to low CO.
107. causes
• Mitral stenosis secondary to rheumatic heart
disease, constrictive pericarditis, or atrial
fibrillation
• Mitral and aortic insufficiency
• Arrhythmias
• Hypertension
• Atherosclerosis with myocardial infarction
(MI)
• Myocarditis
• Ventricular and atrial septal defects
109. Incidence
• Affects less than 5% in ages between 55 – 64
years
• Affects about 10% of people older than 65 years
common characteristics
• Reduced cardiac output
• Shortness of breath
• Peripheral oedema
• Dyspnoea on exertion
110. Classification heart disease by New York Heart
Association
Class I:
No limitation of physical activity
Ordinary activity does not cause fatigue,
dyspnoea, palpitation or anginal pain
Class II:
Slight limitation of physical activity
No symptoms at rest
Ordinary physical activity causes fatigue,
dyspnoea, palpitations or anginal pain
111. Classification cont.
Class III:
Marked limitation of physical activity but
usually comfortable at rest
Ordinary physical activity causes fatigue,
dyspnoea, palpitations, or anginal pain
Class IV:
Inability to carry on any physical activity
without any discomfort
Cardiac insufficiency symptoms or angina may
be present
Increased discomfort for any activity
undertaken
112. complications
• Pulmonary oedema
• Organ failure, especially the brain and kidneys
• Myocardial infarction
• Pleural effusion
• Left ventricular thrombus
113. Complications cont.
o Hepatomegaly (right ventricular failure)
o Splenomegaly (in right ventricular failure)
o Ascites (in right ventricular failure)
o Dysarrhythmias- due to enlargement of
chambers of the heart
o Cardiomyogenic shock
114. Diagnostic assessments
History of:
• A disorder or condition that can precipitate
heart failure
• Dyspnoea or paroxysmal nocturnal dyspnoea
• Peripheral oedema
• Fatigue
• Weakness
• Insomnia
115. History of:
• Anorexia
• Nausea
• Sense of abdominal fullness, due to right-
sided heart failure
• Substance abuse e.g. alcohol, drugs, tobacco.
116. Physical exam findings
• Cough that produces pink, frothy sputum
• Cyanosis of the lips and nail beds
• Orthopnoea
• Pale, cool, clammy skin
• Diaphoresis
• Jugular vein distension
• Ascites resulting poor venous return from
abdomen and liver congestion
• Tachycardia
• Pulsus alternans- weak pulse alternating with
strong one
118. Lab test results:
• B-type natriuretic peptide immunoassay is
elevated
• Liver function tests e.g. ALT, AST, LDH, serum
bilirubin, and total protein and albumin levels are
evaluated to show effect of heart failure on the
liver
• Thyroid function tests e.g. TSH, TH levels done
because both hypothyroidism and
hyperthyroidism can be primary or contributory
factor for heart failure
• In acute heart failure, ABGs done to evaluate gas
exchange in lung tissues
119. Imaging results
• Chest x-ray shows increased pulmonary
markings, interstitial oedema, or pleural effusion
and cardiomegaly
• Radionuclide imaging to evaluate ventricular
function and size
• Serum electrolytes measured to evaluate fluid
and electrolyte status
• Urinalysis, BUN and serum creatinine done to
evaluate renal function
120. Diagnostic procedures
• ECG reflects heart strain or enlargement or
ischemia; atrial enlargement, tachycardia,
extrasystole, or atrial fibrillations
• Pulmonary artery pressure monitoring typically
shows elevated pulmonary artery wedge
pressures, left ventricular end-diastolic pressure
in left-sided heart failure, and elevated right
atrial or central venous pressure in right-sided
heart failure
121. Management
General management:
• Antiembolism stockings to promote venous return
• Elevation of lower extremities to relieve oedema
• Sodium restricted diet to prevent fluid retention
• Fluid restriction to prevent fluid overload
• Calorie restriction if indicated to prevent obessity
• Low-fat fat diet to prevent atherosclerosis
• Walking programs to reduce weight to optimum
level
• Activity as tolerated to keep fit and prevent
dependance
122. Medications
• Oxygen therapy as necessary
• Diuretics, such as frusemide, bumetanide,
torsemide, metolazone and hydrochlorothiazide
• Inotropic drugs such as digoxin (digitalis),
dobutamine, and dopamine to reduce heart rate
and improve cardiac output
• Vasodilators such as nitrates (nitroglycerin),
sodium nitroprusside, isosorbide, and nesiritide-
causes dilatation of arteries and veins
• Angiotensin-converting enzyme inhibitors, such as
captopril, enalapril, and lisinopril
123. • Angiotensin-receptor blockers, such as losartan,
valsartan, and irbesartan to prevent action of
angiotensin II and produce vasoconstriction and
increased salt and water excretion. Full effect
experienced after 3-6 weeks.
• Calcium channel blockers, such as amiodipine,
felodipine, nefedipine, verapamil to block
movement of extracellular Ca++ into cells,
causing vasodilation and decreased HR,
conractility and systemic vascular resistance
124. • Potassium –sparing diuretics e.g. amiloride and
spilonolactone (Aldactone) for exchange of K+ and
Na+ in distal renal tubules and reduce excretion of
K+, H+, Ca++ and Mg++
• Beta-adrenergic blockers, such as atenolol,
metoprolol, propranolol (inderal) and carvedilol
• Anticoagulants, such as warfarin
• Morphine- decreases preload and afterload in acute
decompesated heart failure and pulmonary oedema,
dilates pulmonary and systemic blood vessels.
125. Surgical intervention
• For valvular dysfunction with recurrent acute
heart failure, surgical replacement
• Heart transplant – transfer of a heart from one
person (especially for one who has suffered
massive brain dead) to another
• Ventricular assist device
• Stent placement
126. Nursing management
Nursing Diagnoses
• Decreased cardiac output related to altered
contractility, altered preload and altered stroke
volume as evidenced by jugular vein distension,
orthopnoea, S3, S4
• Impaired gas exchange related to increased
preload and alveolar capillary membrane
changes AEB dyspnoea, tachypnoea,
restlessness, verbalisation , “am short of breath”
127. • Excess fluid volume related to increased
venous pressure and decreased renal
perfusion secondary to HF AEB edema, rapid
weight gain, oliguria.
• Activity intolerance related to fatigue
secondary to cardiac insufficiency and
pulmonary congestion
• Deficient knowledge: low sodium diet related
to lack of information about disease process
128. Expected client outcomes
• The client will:
Maintain haemodynamic stability
Maintain cardiac output
Carry out activities of daily living without excess
fatigue or decreased energy
Maintain adequate ventilation
Maintain adequate fluid balance
129. Nursing interventions
• Place patient in Fowler’s position
• Give supplemental oxygen
• Provide continuous cardiac monitoring during
acute and advanced stages
• Assist the patient with range-of-motion exercises
• Apply antiembolism stockings
• Check for calf pain and tenderness
• Administer prescribed drugs
• Provide emotional support
130. Monitor closely for the following:
• Daily weight for peripheral oedema and other
signs and symptoms of fluid overload
• Cardiac rhythm
• Intake and output
• Response to treatment
• Vital signs: TPR and BP and report to physician
any deviation
• Mental status
• Peripheral oedema
131. monitoring
• Auscultate for abnormal heart beat and breath
sounds, report any changes immediately
• Blood urea and nitrogen and serum creatinine,
potassium, sodium, and magnesium levels
• Prothrombin time
132. Patient Teachings
• You must the following patient teachings:
Heart failure disorder, diagnosis and treatment
Signs and symptoms of worsening heart failure
When to notify the physician
The importance of follow up-care
The need to avoid high-sodium foods
The need to avoid fatigue
Instructions about fluid restrictions
133. Patient teaching
The need to take weight every morning, at the same
time, before eating, and after urinating, keeping
record of this weight, and reporting weight gain of
1.5 to 2.5 kg in a week
The importance of smoking cessation, if appropriate
Diet education to include low sodium and low
cholesterol diet intake
Weight reduction as needed for optimal wt
management
Medication administration, dosage, possible adverse
effects, and monitoring needs
134. Discharge planning
• Encourage client to attend for follow-ups
• Refer the client to a smoking-cessation
program, if appropriate
136. Risk factors
• Streptococcal infection of pharynx
• Crowded environmental conditions
• Low socioeconomic factors
• Malnutrition
• Immunodeficiency
• Poor access to health care
• Unknown genetic factor in susceptibility to
rheumatic fever
137. Incidence
• Occurs worldwide
• More common in developing countries
• More common before age 15, though it can
affect any age
138. Pathophysiology
• Rheumatic heart disease occurs as a result of autoimmune
response to group A streptococcal throat infection,
causing inflammation of tissue containing M proteins.
• Carditis occurs in about 50% of rheumatic fever:
endocarditis, myocarditis and pericarditis
• Aschoff bodies, localized areas of necrotic tissue
surrounded by immune cells, develop in cardiac tissues
• Endocardial inflammation causes swelling and erythema
of valve structures and small vegetative lesions on valve
leaflets, making them rigid and deformed
• As a result, stenosis and regurgitation occurs , most
commonly on the mitral valve, and heart failure ensues
139. Diagnostic Test Characteristics of RHD
• Elevated WBC
• Reduced RBC
• Elevated erythrocyte sedimentation rate
• C-reactive protein is positive
• Elevated antistreptolysin titer
• Throat culture usually positive of group beta-hemolytic
streptococci
• Elevated cardiac enzymes in severe carditis
• ECG changes: prolonged PR interval
• Chest X-ray may show cardiac enlargement
• Echocardiogram may show valvular damage, enlarged
chambers, decreased ventricular function, pericardial
efffusion
140. Clinical features
• Chest pain
• Tachycardia
• Pericardial friction rub
• Evidence of heart failure (manifestations of heart
failure)
• Heart murmur: S3 and S4 sounds on auscultation
• Cardiomegally
• Pericardial effusion
• Manifestation of rheumatic fever, including
polyarthritis
141. Medical Management
antibiotics to eliminate streptococcal infection,
penicillin for at least 10 days
Erythromycin or clindamycin for a patient allergic
to penicillin
Prophylactic antibiotic therapy continued for 5 to
10 years, penicillin G 1.2 mu IM every 3-4 weeks
Analgesics for pain relief e.g. aspirin or ibuprofen
Corticosteroids e.g. Prednisone to relieve
inflammation (carditis)
142. Nursing intervention
• Find out whether patient reacts with penicillins
• Administer prescribed antibiotics
• Administer analgesics as prescribed
• Administer prescribed corticosteroids
• Stress the importance of bed rest
• Position patient in high Fowler’s position
• Provide oxygen therapy as necessary
• Monitor vital signs
143. Nursing interventions
• Monitor heart rhythm
• Monitor heart and respiratory sounds
• Provide warm moist compresses for local pain
relief
• Allow patient express feelings and concerns
• Provide psychological and spiritual support
• Give balanced diet, low in sodium and fats
144. Patient teaching
• Inform the patient on the disorder, diagnosis and
treatment
• Importance of resuming activities of daily living slowly and
scheduling frequent rest periods
• Inform patient what to do if reacts with penicillin
• Importance of reporting signs of heart failure e.g. severe
dyspnoea
• Prevention of respiratory infections
• Good oral care to prevent gingival infections
• Continue with prescribed prophylactic antibiotics
• Medication administration, dosages and possible adverse
effects
• Clinic follow-up for check-ups
146. TRCUSPID INSUFFICIENCY
Introduction
• Heart condition in which the tricuspid valve doesn’t
function properly
• Also called tricuspid regurgidation
Causes
Rheumatic heart disease
Papillary muscle dysfunction
Carcinod heart disease
Connective tissue disease
Trauma
Endocarditis
Valvular prolapse
Epstein anomaly
147. Incidence:
o Affects both sexes equally
o Usually occurs in childhood
Common characteristics:
• Dyspnoea on exertion
• Peripheral oedema
• Tachycardia
• Fatigue
148. Pathophysiology
• The tricuspid valve is incompetent
• Blood flows back into the atrium
• Fluid overload occurs in the atrium
• Congestive failure occurs, and impendance to the
pulmonary vasculature may result in hypoxaemia
and polycythemia
153. Test results
Imaging:
o Chest X-ray show right atrial and ventricular
enlargement
o Echocardiography shows right ventricular
dilation and prolapse or flailing of the tricuspid
triplets
154. Test results
Diagnostic procedures
Electrocardiography shows right atrial
hypertrophy, right or left ventricular hypertrophy,
and atrial fibrillation, and incomplete right
bundle-branch block
Right-sided heart catheterization shows high
atrial pressure, tricuspid insufficiency, and
decreased and normal output
155. Treatment and medication
• General treatment include
o Underlying cause
o Low-sodium diet
o Fluid restriction
o Activity as tolerated
156. Medications
• Diuretics
• Cardiac glycoside
• Anticoagulants
• Angiotensin-converting enzyme inhibitors
• Oxygen
• Prophylactic antibiotics in some patients before
and after surgery or dental care to prevent
endocarditis
157. Surgery
o Annuloplasty or valvuloplasty to reconstruct
or repair the valve
o valve replacement with a prosthetic valve
158. NURSING CONSIDERATION
Key Outcomes
The patient will:
o Carry out activities of daily living without
weakness or fatigue
o Maintain haemodynamic stability
o Maintain adequate ventilation
159. NURSING INTERVETIONS
• Administer oxygen
• Watch for signs of heart failure or pulmonary
edema
• Alternate periods of activity and rest
• Keep patient’s legs elevated to improve
venous return to the heart
160. Monitoring
• Vital signs and oximetry
• Cardiac rhythm
• Pulmonary artery catheter readings
• Intake and output
• Adverse effects of drug therapy
161. Patient teachings
• Be sure to cover
The disorder, diagnosis and treatment
dietary restrictions and medications
Signs and symptoms that should be reported
The importance of consistent follow-up care
The need to elevated his/her legs when sitting
to relieve oedema
162. Tricuspid valve stenosis
• Is a valvular disease which results in the
narrowing of the orifice of the tricuspid
valve of the heart.
• Obstructs blood flow from the right
atrium to right ventricle
• Fibrosed, retracted tricuspid valve cusps
and fused leaflets narrow the valve
orifice and prevent closure
165. Pathophysiology
• Alterations in the structure of the tricuspid
valve cause incompetence of valve
• Restriction of blood flow into the right
ventricle and, subsequently, to the pulmonary
vasculature occurs
• Obstructed venous return results in hepatic
enlargement, decreased pulmonary blood
flow, peripheral oedema, and right atrial
enlargement
166. Incidence
• Affects females slightly more common than
males
Common characteristic
• Dyspnoea on exertion
• Peripheral oedema
• Fatigue
• Ascites
169. • Physical findings:
A low rumbling crescendo-decrescendo
murmur in the tricuspid area heard in 4th
intercostal space at left sternal boarder or
over xiphoid process
Split S1
Hepatomegaly
Ascites
Jugular venous distension
Peripheral oedema
170. Test result
• Imaging
Chest x-ray-reveals cardiomegaly
Echocardiography- used to examine the
size shape and motion of the cardiac
structure
Electrocardiography-this is a graphic
recording of the electrical activity of the
heart
178. Pathophysiology of aortic stenosis
• Stenosis of the aortic valve results in
impendance to foward blood flow
• The left ventricle requires greater pressure to
open the aortic valve
• Added work load increases myocardial oxygen
demands
• Diminished cardiac output reduces coronary
artery blood flow
• Left ventricular hypertrophy and failure result
179. Common characteristics
• Note; many are asymptomatic
• Exertional dyspnea
• Orthopnea
• Pulmonary edema
• Dizziness
• Syncope
• Angina
180. Assessment and diagnostic findings
• History taking
• Physical examination: a loud rough systolic
murmur is heard over the aortic area. Which
may radiate to carotid arteries
Other distinguishing finding:
• Diminished carotid pulse
• Distinct lag between carotid artery pulse and
apical pulse
181. • Diagnostic procedures include:
Echocardiography- shows decreased valve
area and hypertrophied left ventricle.
Chest x-ray-shows cardiomegaly
Catheterization-shows increased pressure
across the aortic valve and in the left
ventricle
Electrocardiography-shows left ventricular
hypertrophy and artrial fibrillation
184. Aortic insufficiency
• Is the back-flow of blood into the
ventricles causing fluid excess.
Incidence
• Occurs most commonly in males
• When associated with mitral valve
disease, it more common in females
185. Causes
• Rheumatic fever
• Hypertension
• Infective endocarditis
• Aortic dissection- tearing or rupturing of
the aorta
• Aortic aneurysm- weakening, thinning
and distension of the walls of the aorta
186. pathophysiology
• Blood flows back into the left ventricle
during diastole causing increased left
ventricular diastolic pressure
• This results in volume overload, dilation
and eventually hypertrophy of the left
ventricle
• Excess fluid volume also eventually results
in increased left arterial pressure and
increased pulmonary vascular pressure.
187. Clinical manifestation
• Most develop without symptoms
• Palpitations
• Marked and visible carotid pulses
• Fatigue
• Orthopnea
• Angina
• Paroxysmal nocturnal dyspnea
188. Physical findings
• Corrigans pulse-carotid (also called water-
hammer pulse) pulse that increases rapidly then
collapses
• Pulses bisferiens (having two beats)-striking
twice
• Pulsating nail bed and Quincke's’ sign- visible
pulsation of red coloration on the nail bed (seen
in aortic regurgitation)
189. • Wide pulse pressure (systolic pressure minus
diastolic pressure )
• A high pitched blowing decrescendo murmur
that radiates from the aortic valve area to the
left sternal border.
190. Imaging studies includes
Chest x-ray-shows cardiomegaly and
pulmonary vein congestion
Echocardiography- shows cardiomegaly
and thickening of the valve cusps
Other tests include
• Electrocardiography – shows sinus
tachycardia and hypertrophy
• Cardiac catheterization-shows degree of
aortic insufficiency
194. Nursing consideration
Key outcomes
The patient will
• Perform activities of daily living without
excess fatigue or exhaustion
• Avoid complications
• Maintain cardiac output
195. Nursing consideration
• Demonstrate hemodynamic instability
• Maintain balanced fluid status
• Maintain joint mobility and range of
motion
• Develop an demonstrate adequate
coping skills
196. Nursing interventions
• Give prescribed drugs
• Maintain a low sodium diet
• Stress the importance of bed rest
• Alternate periods of activity with rest
• Allow the pateint to voice concerns
about the effect of activity restrictions
197. Nursing interventions
• Keep the patients legs elevated while he
sits on a chair
• Place the patient in an upright position
and administer oxygen as needed
• Allow patient express fears and concerns
198. Monitoring
• Vital signs
• Intake and output
• Signs and symptoms of heart failure
• Signs and symptoms of progressive aortic
stenosis
• Daily weight
• Arrythmias
• Respiratory status
199. monitoring
If patient had surgery, monitor
• Signs and symptoms of thrombus
formation
• Hemodynamic stability
• Arterial blood gases levels
• Blood chemistry results
• Chest x-ray result
200. Patient teaching
• Teach on diagnosis, progressive nature of the valvular
heart disease and the treatment plan
• Patient is taught to report new symptoms to the
health care provider
• Emphasize the need for prophylactic antibiotic
therapy before any invasive procedure
• Patient is advised to rest and sleep sitting in chair/
bed with head elevated when experiencing symptoms
of pulmonary congestion
201. Mitral stenosis
• Is a valvular heart disease characterized
by the narrowing of the orifice of the
mitral valve of the heart, thereby
obstructing blood flow from the left
atrium into left ventricle during diastole
• The disorder is chronic and progressive
• Normally the orifice is 3-6cm
• Mild mitral stenosis: orifice is 2cm
• Severe mitral stenosis: orifice of 1cm
202. Causes
• Rheumatic fever
• Congenital anomalies
• Atrial myxoma- a benign mucous tumor
of the connective tissues.
• Endocarditis
• Rheumatoid arthritis
203. Incidence
• Two-third of the patients are female
• It also occurs in 40% of patients with
rheumatic heart disease
204. Pathophysiology
• The opening narrows to the width of a
pencil
• The left atrium has difficulty moving
blood into the ventricle because of the
increased resistance
• The left atrium stretches and
hypertrophies because of the increased
blood volume.
205. pathophysiology
• The pulmonary circulation becomes
congested, leading to pulmonary
hypertension
• As a result the right atrium must contract
against the high pressure of the
pulmonary hypertension causing right-
sided heart failure
206. Clinical manifestation
• Shortness of breath
• Dyspnea on exertion
• Chest pain
• Palpitations
• Hemoptysis
• Peripheral and facial cyanosis
207. Diagnostic findings
• History taking: for specific symptoms
• Physical examination: a loud S1, a split S2, mitral
opening snap may be heard
Identify the murmur: a low rumbling crescendo-
decresendo murmur in the mitral valve area,
accompanied by palpable thrill (vibration)
• Diagnostic procedures
Cardiac catheterization-shows increased pressure
in the left atrium
Electrocardiography reveals left artrial
enlargement
208. Medical management
• Digitalis e.g. Digoxin
• Diuretics e.g. frusemide
• Oxygen therapy
• Anticoagulant e.g. warfarin
• Nitrates e.g. nitroglycerin
• Calcium channel blockers e.g. nifedipine
• Beta-adrenergic blockers e.g. atenolol
211. Mitral valve insufficiency
• This is a valvular disease of the mitral
valve that allows the backflow of blood
from the left ventricle to the left atrium.
• It may be:
Acute.
Chronic compensated.
Chronic decompensated.
212. Causes
• Rheumatic fever
• Cardiomyopathy- chronic disorder of the
heart muscles
• Infective endocarditis
• Mitral valve prolapse
• Myocardial infarction- death or necrosis
of myocardial cells
• Congenital anomalies
213. Pathophysiology
• Blood from the left ventricle flows back
into the right atrium during systole
causing the atrium to enlarge to
accommodate the backflow
• Left ventricles dilate to accommodate the
increased volume from the atrium and to
compensate for diminishing cardiac
output
214. Pathophysiology
• Ventricular hypertrophy and increased
end-diastolic results in increased
pulmonary artery pressure, eventually
leading to left sided and right sided heart
failure
216. Diagnostic findings
• History taking: orthopnea, dyspnea,
fatigue, angina, palpitations
• Physical examination: tachycardia,
crackles.
• A high pitched rumbling pansystolic
murmur that radiates from the mitral
area to the left axillary line
217. Test result
• Imaging
Chest x-ray-reveals left atrial and
ventricular enlargement
Echocardiography- shows abnormal
valves structure
218. management
Medications such as
• Diuretics e.g. furosemide
• Inotropic agents such as digoxin
• Angiotensin converting enzyme inhibitors eg
captopril
• Oxygen
• Anticoagulant e.g. warfarin
• Prophylactic antibiotic
• Vasodilators such as nitroprusside
221. Summary
• Valvular diseases mainly affect the valves. They
can be congenital or acquired.
• There are various types of valve disorders
classified broadly as stenotic disorders or
regurgitation disorders.
• Symptoms present as those of heart failure.
• Management involves medical, surgical and
nursing management.
• Common complication is heart failure.
222. Conclusion on valvular diseases
• If valvular diseases progress they lead to heart
failure.
• Proper management and follow-up should
therefore be emphasized:
Surgical treatment
Treament include medications and surgical
interventions:
Valvuloplasty- repair of valves
Commissurotomy- separating fused leaflets
223. Surgical treatment of valvular
disorders
Annuloplasty-repair of junction of valve and
muscular heart wall
Leaflet repair- to remove extra tissue leaflets
Chordoplasty- repair of chordae tendineae
Valve replacement- when above measures have
failed, valve replacement is perfomed, two types:
mechanical valves (bileaflet, tilting-disk, ball-and-
cage design) and tissue valves: 3 types
(bioprostheses, homografts, autoggrafts)
224. Coronary Artery Disease
Introduction
• Type of blood vessel disorder including
atherosclerosis, that is, deposits of fat
(atheromas) that hardens with age
• Atherosclerosis occludes the coronary artery by
fibrous, fatty plaque, manifested by angina
pectoris, acute coronary syndrome and /or
myocardial infarction
• Primary effect include: loss of oxygen and
nutrients to myocardial tissue because of
diminished coronary blood flow
225. Pathophysiology
• Increased blood levels of low-density lipoprotein
(LDL) irritate or damage the inner layer of coronary
vessels
• LDL enters the vessel after damaging the protective
barrier, accumulates, and forms a fatty streak
• Smooth muscle cells move to the inner layer to
engulf the fatty substance, produce fibrous tissue,
and stimulate calcium deposition
• Cycle continues, resulting in transformation of fatty
streak into fibrous plaque, and eventually, a
coronary artery disease (CAD) evolves
226. Pathophysiology
• Oxygen deprivation forces the myocardium to
shift from aerobic to anaerobic metabolism,
leading to accumulation of lactic acid and
reduction of cellular pH cause angina pectoris
• The combination of hypoxia and reduced energy
availability, and acidosis rapidly impairs left
ventricular function
227. Pathophysiology
• The strength of contractions in the affected
myocardial region is reduced as the fibres
shorten inadequately, result in less force and
velocity
• Wall motion is abnormal in ischemic area,
resulting in less blood being ejected from the
heart with each contraction
229. Risk factors
• Family history
• High serum cholesterol levels above 200 mg/dL
• Smoking
• Diabetes
• Hormonal contraceptives
• Obesity: BMI above 30 kg/m2 or waist over 40
inches
• Sedentary lifestyle
• Stress/psychological states e.g. depression,
increased stimulation of SNS
230. Risk factors
• Increased homocysteine levels : broken products
of aminoacid methionine, which lead to
atherosclerosis
• Hypertension
• Substance abuse e.g. cocaine,
methamphetamine cause coronary spasms
resulting in myocardial ischemia
• Metabolic syndrome: cluster risk factors e.g.
insulin resistance, obesity, hypertension, high
serum lipids levels
231. Incidence
• Occurs after age 40
• Males eight times more susceptible than
premenopausal females
• Risk increased by family history
• White males more susceptible than nonwhite males;
nonwhite females more susceptible than white
females
• In America alone, more than 11 million people
affected by CAD
Common characteristic
Angina
232. Complications
• Arrhythmias- heart beat irregularities
• Myocardial infarction- death of cardiac myocytes
• Heart failure- insufficient cardiac out to meet body’s
metabolic activities
• Cardiac shock due to inadequate oxygen and nutrient
supply
• Ventricular aneurysm
• Pericarditis due to cardiac compression
• Dressler syndrome: pericarditis with effusion and fever
• Papillary muscle dysfunction: if infarcted area
includes/adjacent papillary muscle attached to mitral valve
233. Diagnostic assessment
History of:
• Angina that may radiate to the left arm, neck, jaw, of
shoulder blade
• Commonly occurring after physical exertion but possibly
following emotional excitement, exposure to cold, or
ingestion of a large meal
• May develop during sleep; symptoms wake the patient
• Nausea
• Vomiting
• Fainting
• Sweating
• Stable angina: predictable and relieved by rest or nitrates
234. History of:
• Unstable angina: increases in frequency and
duration and is more easily induced and
generally indicates extensive or worsening
disease, and, untreated, may progress to
myocardial infarction
• Crescendo angina: an effort pain-induced
occurring with increasing frequency and
decreasing provocation
• Prinzmental’s or variant angina pectoris: severe
non-effort produced pain occurs at rest without
provocation to spasm
235. Physical findings
• Cool extremities- due to poor blood supply
• Xanthoma- soft, yellow skin plaques or nodules
containing lipoprotein deposits inside histiocytes
related to hyperlipidemia
• Arteriovenous nicking of the eye
• Obesity-
• Hypertension
• Positive Levine’s sign (holding fist to chest)
• Decreased or absent peripheral pulses
236. Imaging test results
• Myocardial perfusion imaging with
radionucleotide during treadmill exercise shows
ischemic areas of myocardium, visualized as
“cold spots”.
• Pharmacologic myocardial perfusion imaging in
arteries with stenosis shows decrease in blood
flow proportional to the percentage of occlusion
• Stress echocardiography may show abnormal
wall motion
237. Imaging test results
• Coronary angiography reveals the location and
the degree of coronary artery stenosis or
obstruction, collateral circulation, and the
condition of the artery beyond the narrowing
• Multiple-gated acquisition scanning
demonstrates cardiac wall motion and reflects
injury to cardiac tissue
238. Diagnostic procedures findings
• ECG may be normal between anginal episodes
• During angina, ECG may show ischemic changes
• Exercise stress testing may be done to detect ST-
segment changes during exercise, indicating
ischemia, and to determine a safe exercise
prescription
239. Treatment/Management
General management:
• Stress reduction techniques essential especially if
known stressors precipitate pain
• Lifestyle modifications, such as smoking
cessation and maintaining ideal body weight
• Low-fat, low-sodium diet
• Activity restrictions possible
• Regular exercise as tolerated
240. Medications
• Antianginals, such as ranolazine and nitroglycerin
• Beta adrenergic blocker such as metoprolol
• Calcium channel blocker such as diltiazem
• Antiplatelets, such as ticlopidine and aspirin
• Antilipemic such as simvastatin, atorvastatin,
pravastatin
• Antihypertensive such as lisinopril
241. Surgery
• Coronary artery bypass graft
• “Keyhole” or minimally invasive surgery
• Angioplasty
• Endovascular stent placement
• Laser angioplasty
• Atherectomy
242. Nursing Management
Nursing diagnoses:
• Acute pain related to imbalance between
myocardial oxygen supply and demand
• Decreased cardiac output related to myocardial
injury
• Anxiety related to actual thread of death, pain,
possible lifestyle changes
• Activity intolerance related to fatigue
• Imbalanced nutrition: more than body requirement
related to obesity
• Ineffective self-health management related to lack
of knowledge of disease process
243. Expected patient outcomes
The client will:
Maintain hemodynamic stability
Plan menus appropriate to prescribed diet
Demonstrate understanding of the disease
process
Express concern about self-concept, self-esteem,
and body image
Express feeling of increased comfort and
decreased pain
244. Nursing interventions
• Ask the patient to grade the severity of his/pain
on scale of 0 to 10
• Keep nitroglycerin available for immediate use
• Instruct patient to call immediately whenever he
or she feels pain and before taking nitroglycerin
• Observe for signs and symptoms that may
signify worsening of condition
245. Nursing interventions
• Prepare patient for surgical intervention if
indicated
• Maintain bed rest immediately postoperatively
with the head of the bed elevated at least 30
degrees
• Encourage coughing, deep breathing and
incentive spirometer use postoperatively
• Encourage early ambulation after surgery
246. Monitoring
• Vital signs to identify any abnormality
• Hemodynamic status
• Fluid intake and output
• Effectiveness of pain medication during anginal
episodes
• Abnormal bleeding and distal pulses following
intervention procedures
• Respiratory status
• Chest tube drainage, after surgery
• Cardiac rate and rhythm
• Cardiovascular status
247. Patient teaching
On patient teaching, ensure to cover the following:
Risk factors for CAD
Avoidance of activities that precipitate pain
The need to follow the prescribed drug regimen
Effective coping mechanism to deal with stress
Low-sodium and low-calorie diet
The importance of regular, moderate exercise
248. Discharge planning
• Refer the patient to a weight-loss program, if
needed
• Refer the patient to a smoking-cessation
program, if needed
• Refer the patient to cardiac rehabilitation
program, if indicated
250. OBJECTIVES
1. To describe Thrombophlebitis.
2. To state the cause of Thrombophlebitis.
3. To list the risk factors of Thrombophlebitis.
4. To state the incidence of Thrombophlebitis.
5. To describe the pathophysiology of
Thrombophlebitis.
6. To list the signs and symptoms of
Thrombophlebitis.
7. To explain the diagnosis of Thrombophlebitis.
8. To discuss the management of Thrombophlebitis.
9. To describe the complications of Thrombophlebitis.
10 . To highlight patient teaching on the condition
Thrombophlebitis.
251. Introduction
• It is an acute condition that’s characterized by
inflammation of the vein accompanied by
thrombus formation.
• Typically occurs in the cusps because the
venous stasis encourages accumulation of and
adherence of fibrin and platelets.
252. Cause of Thrombophlebitis
• Inflammation due to a blood clot in the vein.
Risk Factors
• Prolonged bed rest
• Trauma
• Surgery
• pregnancy and childbirth
• Hormonal contraceptives or estrogen
replacement therapy.
253. Risk factors
• Fracture of the spine, femur, pelvis
• Smoking
• Obesity
• Venous stasis
• Family Hx of clotting disorder
Incidence
• Increase use of subclavian vein catheters
• Risk for DVT increases after age 20.
254. Pathophysiology
• Alteration in epithelial cell lining causes
platelet aggregation and fibrin entrapment of
RBCs, WBCs and platelets.
• The thrombus initiates a chemical
inflammatory process in the vessel epithelium
that leads to fibrosis which may occlude the
vessel lumen or embolize.
255. Signs and symptoms
• Inflammation (swelling) in the part of the body
affected
• Pain in the part of the body affected
• Skin redness (not always present)
• Warmth and tenderness over the vein
256. Diagnosis and Assessment
i. History
Asymptomatic in up to 50% of patients with DVT
Possible tenderness, aching, severe pain in
affected leg or arm, fever, chills, malaise in the
past.
ii. Physical findings
• Possible tenderness, aching, severe pain in
affected leg or arm, fever, chills, malaise
• Positive Homan’s sign.
• Lymphadenitis in case of extensive vein
involvement.
257. • iii. Test results
Diagnostic procedures:
Doppler ultrasonography indicates reduced
blood flow to a specific area and any
obstruction to venous blood flow.
Phlebography confirms the diagnosis and
shows filling defects and diverted blood flow.
258. Management
General:
• Application of warm moist compresses to the
affected area.
• Antiembolism stockings
• Bed rest with elevation of the affected extremity.
Medications
• Anticoagulants i.e. heparin and warfarin
• Thrombolytics (e.g., alteplase) is given within the
first 3 days after acute thrombosis
• Analgesics i.e. NSAIDs
259. Management
Surgery
Simple ligation or clipping of the vein
Embolectomy- is the emergency surgical removal
of emboli which are blocking blood circulation.
Caval interruption with a transvenous placement
of a vena cava filter.
Nursing Management
Key outcomes:
The patient will:
260. Nursing consideration
• Maintain collateral circulation
• Express feelings of increased comfort and decreased
pain
• Maintain tissue perfusion and tissue oxygenation
• Develop no signs of infection
Nursing Interventions
• Enforce bed rest and elevate affected leg
• Apply warm compresses
• Administer prescribed antibiotics
• Regulary measure circumference of the affected leg and
compare with the other
• Administer prescribed anticoagulants
261. Nursing interventions
• Encourage or perform ROM exercises
• Apply antiembolic stockings
• Encourage early ambulation.
Monitoring
• Signs and Symptoms of bleeding
• Vital signs
• Clinical features of heparin induced
thrombocytopenia
• Manifestations of pulmonary embolism
• Response to treatment
262. Patient Teaching
• Stress on the importance of follow up studies
to monitor anticoagulant therapy
• Avoid prolonged sitting or standing
• Proper application of antiembolism stockings
• Importance of adequate hydration
263. Thrombophlebitis (venous thrombosis)
Introduction:
• Inflammation of the vessel wall with information of a clot
(thrombus); may affect superficial or deep veins
(deep venous thrombosis)
• Most frequent veins affected are the saphenous,
femoral and popliteal
• Can result in damage to the surrounding tissues,
ischemia, and necrosis
• Risk factors include: obesity, HF, prolonged
immobility, MI, pregnancy, oral contraceptives,
trauma, sepsis, cigarette smoking, dehydration,
severe anaemia, venous cannulation, complication
of surgery
264. Pathophysiology
• The three major pathologic factors (Virchow’s
triad) predisposing to thrombus formation are:
Blood stasis
Injury to venous endothelial lining, and
Hypercoagulability of blood
• A venous thrombosis usually being in a valve
cusp where platelets adhere to the endothelium
and then to each other. As the process continues,
a fibrin mesh covers the platelets (white
thrombus).
265. Pathophysiology cont.
• As the thrombus grows, it causes obstruction to
blood flow. This allows red blood cells, platelets and
fibrin to stagnate and form a red thrombus
• If thrombus occludes blood flow, venous congestion
will develop unless collateral circulation is
established
• Within a few days of thrombus formation, the body
can dissolve the clot or may convert it to fibrous
tissue that could incorporate and destroy the valve
• Complications of venous thrombus are pulmonary
emboli, and venous insufficiency
266. Assessment findings
• Pain in the affected area/extremity
• Superficial vein: tenderness, redness, induration
along course of the vein, palpable cord,
distension of superficial veins, prominent venous
collaterals
• Deep vein: swelling, extreme oedema formation,
venous distension of limb, tenderness over
involved vein, positive Homan’s sign, cyanosis
• Elevated WBC, and ESR
268. Causes
• Venous stasis:
bed rest or immobilisation
Obesity
History of vasicosities
Spinal cord injury
Age > 65 years
269. causes
• Altered Coagulation:
Cancer
pregnancy
Oral contraceptive use
Protein S deficiency
Antiphospholipid antibody syndrome
Factor V Leiden defect
Prothrombin G20210A defect
Hyperhomocysteinemia
Elevated factors II, VIII, IX, XI
Polycythemia
Septicemia
270. Diagnostic evaluation
• Venography (phlebography): increased uptake
of radio
• Plethysmography: non-invasive test measuring
venous flow
• Duplex ultrasonography: non-invasive
visualization of vein and measurement of velocity
of venous blood flow
• I-125 fibrinogen scanning
• Magnetic resonance imaging: non-invasive
detection of deep vein thrombosis
• Ascending contrast venography: uses injected
contrast medium to locate site of thrombus and
size
272. Treatment
• Bed rest
• Elevate extremities
• Local heat
• Elastic hose
• Analgesics/antiinflammatories e.g. indomethacin or
naproxen
• Anticoagulation initially with low-moleculat weight
heparin
• Anticoagulate with warfarin (comoudin)
• May use thrombolytic drugs e.g. streptokinase or
tissue plasminogen activator to acccelerate clot lysis
• Iliofemoral venous thrombectomy
273. Nursing diagnoses
• Pain related to inflammation secondary to
thrombosis in the involved vein
• Ineffective peripheral tissue perfusion related to
occlusion of vein, obstruction of blood flow
• Ineffective protection related to use of
anticoagulants causing bleeding/hemorrhage
• Impaired physical mobility related to severe pain,
oedema
• Risk for ineffective tissue perfusion:
cardiopulmonary related to pulmonary embolism
274. Nursing interventions
• Promote resolution of thrombus and prevent
further thrombus formation by:
promoting bed rest
Administering anticoagulants as ordered
Applying elastic or pneumatic hose as ordered
Elevating affected extremity
Frequent position changes
Deep breathing and fluid intake
Providing good skin care
275. Promote resolution and thrombus
formation
Teaching patient to cease smoking
Not massaging the affected extremity
Not to stand or sit in any position for long
periods of time
To avoid use of constricting garments like ……
To perform calf and quadriceps contractions
several times per hour
276. • Monitor status of extremity by:
Assessing quality of pulses
Assessing colour
Assessing temperature
Assessing rapidity of capillary refill
Assessing for presence of oedema and pain
Monitoring of circumference of the leg daily
Monitoring for skin breakdown or ulcers
277. • Promote pain relief by:
Providing analgesics as ordered
Elastic or pneumatic stockings as ordered
Applying warm compresses as ordered
Encouraging frequent position changes
Elevation of affected extremity and rest
periods
278. On-going monitoring and assessments
• Monitor complications of pulmonary embolus
and bleeding by:
Monitoring for tachycardia
Monitoring for dyspnoea
Monitoring for chest pain
Monitoring for hemoptysis
Monitoring for changes in breath sounds
Monitoring for changes in vital signs
279. On-going monitoring and assessment
Monitoring for changes in arterial blood gases
Assessing results of serial hemoglobin and
hematocrits
Assessing PT’s, PTT’s, or APTT’s every day
Observing for blood in urine
Observing for bleeding from gums and epistaxis
• Assessing for and instituting measures to
alleviate anxiety
280. Client’s teaching
• Teach patient about:
Treatment measures including, laboratory tests, and
their purposes, Medications and side effects
Basic pathophysiology of thrombus formation
Measures to prevent future episodes of the
condition
Prescribed exercises
Monitoring for signs of bleeding
Recurrent thrombus and pulmonary emboli
Need to stop smoking
Correct use of elastic hose/pneumatic stockings
281. Client teachings
Not using constricting clothing
Appropriate methods of heat applications
Need for frequent change of position while
standing or sitting
Wearing of a medic alert bracelet if
anticoagulated
Importance of follow-up visits and laboratory
tests as scheduled
283. VARICOSITY (VARICOSE VEINS)
• Dilated tortuous veins, engorged with blood
resulting from improper venous valve
function
• Primary varicose veins originating in
superficial veins, especially saphenous and
branches
• Secondary varicose veins occurring in deep
and perforating
284. Pathophysiology
• A weakened valve allows backflow of blood to the
previous valve
• If the valve can’t hold the pooling blood, it becomes
incompetent, allowing even more blood to flow
backward
• As volume of venous blood builds, pressure in the
vein increases and the vein becomes distended.
• As the vein stretches, it loses elasticity, enlarges,
and becomes tortuous
• Hydrostatic pressure increases, plasma is forced out
into surrounding tissue, and oedema results
285. causes
• Congenital weakness of valves or venous wall
• Pregnancy
• Tight clothing
• Occupations that require long standing
• Deep venous thrombosis
• Trauma
286. Risk factors
• Prolonged standing or time on feet
• Obesity
• Heavy lifting
• Pregnancy
Incidence
Common in middle adult
Primary varicose veins: family tendency, affect
both legs, twice as common in females as males
Secondary varicose veins: usually in only one leg
287. Common characteristics
• Dilated, purple, rope-like veins
• Oedema of calves and ankles
• Venous stasis ulcers
Complications
Venous insufficiency
Venous stasis ulcers
288. Assessment
History include:
May be asymptomatic
Feeling of heaviness in the legs, worsening in
evenings and during warm whether
Leg cramp at night
Diffuse, dull, aching leg pain after prolonged
standing or sitting
Aching legs during menses in women
Exercise relieves pain due to venous return
improvement
289. Physical findings
• Dilated, purplish, ropelike veins in the calf
• Orthostatic oedema and stasis of the calves
• Nodules along affected veins and valve
incompetence
• In chronic condition, venous stasis ulcers,
which should be differentiated from arterial
and diabetic ulcers
290. Test results
• Imaging
Ascending and descending venography reveals
venous occlusion and collateral circulation
• Diagnostic procedures
Photoplethysmography, a noninvasive test,
characterizes venous blood flow by showing
changes in the skin’s circulation
Dopler ultrasonography quickly and acurately
shows presence or absence of venous backflow in
deep or superficial veins
Venous outflow and reflux plethysmography may
be used to identify deep venous occlusion
291. Treatment
General:
• Put on elastic bandage
• Avoid tight clothing
• Wear antiembolism stockings for moderate
varicosity
• Severe varicosities are treated with custorm fitted,
surgical weight stockings with graduated pressure
• Avoid prolonged standing
• Routine exercise
• Elevation of the legs
292. Medication/surgery
• Medication:
Sclerotherapy- the injection of irritating chemicals
into a vein to destroy it
• Surgical interventions include:
Stripping (removing all contents from affected vein)
and ligation (the application of a ligature)
Laser surgery- use of intense beam of light to
vaporize the blockage
Catheter-assisted procedure
Phlebectomy: surgical removal of a vein or part of a
vein
Endoscopic vein surgery
293. Nursing considerations
Key outcomes
The patient will:
• Express understanding of disorder and treatment
• Maintain adequate distal and collateral
circulation
• Express feelings of increased comfort and
decreased pain
• Carry out activities of daily living without excess
fatigue or discomfort
294. Nursing considerations
• After stripping and ligation or after injection of a
sclerosing agent, administer agent analgesics as
ordered to relieve pain
• Frequently check circulation in toes and observe
elastic bandages for bleeding
• When ordered, rewrap bandages at least once
per a shift, wrapping from toe to thigh, with the
leg elevated